Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Radka Hobzova has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acetoacetates Derived From Vegetable Oils: A Platform for Tailor‐Made Vinylogous Urethane Foams

    by Krzysztof Polaczek, Priscilla de Souza Lima, Olga Gotkiewicz, Ondrej Kopilec, Radka Hobzova, Lívia Kanizsová, Mikelis Kirpluks, Ondrej Sedlacek, Hynek Beneš

    The increasing demand for flexible and rigid polyurethane foams has intensified the need for sustainable end‐of‐life management strategies. In this study, a strategy combining vinylogous urethane chemistry with oleochemistry to develop non‐isocyanate, bio‐based polymer foams with enhanced recyclability is employed. This approach presents a universal platform for fabrication of recyclable foams with tunable mechanical properties, ranging from flexible, elastic foams to rigid, stiff materials, owing to the versatile chemistry of vinylogous urethane networks. Moreover, the ability to control gelling and foaming kinetics leads to the fabrication of non‐isocyanate foams with beneficial low‐density (60–70 kg m −3 ) that can compete with typical conventional polyurethane foams. These findings indicate that the vinylogous urethane foams derived from renewable vegetable oils provide a promising strategy for addressing end‐of‐life concerns associated with conventional polyurethane foam applications.

  • Open Access

    Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment

    by Radka Hobzova, Jakub Sirc, Kusum Shrestha, Barbora Mudrova, Zuzana Bosakova, Miroslav Slouf, Marcela Munzarova, Jan Hrabeta, Tereza Feglarova, Ana-Irina Cocarta

    Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.


  • Open Access

    The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant

    by Martina Kodetova, Radka Hobzova, Jakub Sirc, Jiri Uhlik, Katerina Dunovska, Karel Svojgr, Ana-Irina Cocarta, Andrea Felsoova, Ondrej Slanar, Martin Sima, et al.

    Transscleral diffusion delivery of chemotherapy is a promising way to reach the vitreal seeds of retinoblastoma, the most common intraocular malignancy in childhood. In this in vivo study, the delivery of topotecan via lens-shaped, bi-layered hydrogel implants was combined with transconjunctival cryotherapy to assess whether cryotherapy leads to higher concentrations of topotecan in the vitreous. The study included 18 New Zealand albino rabbits; nine rabbits received a topotecan-loaded implant episclerally and another nine rabbits received transconjunctival cryotherapy superotemporally 2 weeks before implant administration. Median vitreous total topotecan exposures (area under the curve, AUC) were 455 ng·h/mL for the cryotherapy group and 281 ng·h/mL for the non-cryotherapy group, and were significantly higher in the cryotherapy group, similar to maximum levels. Median plasma AUC were 50 ng·h/mL and 34 ng·h/mL for the cryotherapy and non-cryotherapy groups, respectively, with no statistically significant differences between them. In both groups, AUC values in the vitreous were significantly higher than in plasma, with plasma exposure at only approximately 11–12% of the level of vitreous exposure. The results confirmed the important role of the choroidal vessels in the pharmacokinetics of topotecan during transscleral administration and showed a positive effect of cryotherapy on intravitreal penetration, resulting in a significantly higher total exposure in the vitreous.


  • Open Access

    Establishment of a Xenograft Model of Human Retinoblastoma in Pig Eyes

    by Martina Kodetova, Karel Svojgr, Radka Hobzova, Jakub Sirc, Jan Hrabeta, Barbara Feriancikova, Daniela Kodetova, Jiri Uhlik, Ana-Irina Cocarta, Kusum Shrestha, et al.

    Retinoblastoma (Rb), the most common primary intraocular tumor in childhood, is specific in its location inside the eye globe and, in more advanced disease, in the occurrence of vitreous seeds. Finding an effective treatment thus requires an adequate tumor animal model. As a large animal model has not yet been described, the purpose of this study was to create a porcine Rb model. Eight male minipigs (8 eyes) without immunosuppression were used in this study. A suspension of cultured WERI-Rb-1 cells, 100 µl with a concentration of 106 cells/ml, was injected into the subretinal space via pars plana vitrectomy (4 eyes) or directly into the vitreous (4 eyes). The animals were examined weekly using a fundus camera, ultrasound and optical coherence tomography. After a period of 4 weeks, the animals were euthanized and enucleated eyes were histopathologically examined. Rb cell growth and the establishment of a tumor under the retina and/or in the vitreous were observed in all 4 eyes after subretinal application and in 2 of 4 eyes after intravitreal application of Rb cells. Tumor growth was detectable with fundoscopy starting at week 1 postinjection. The generation of the tumor was also confirmed histopathologically. The successful creation of Rb tumors in the eyes of nonimmunosuppressed pigs was demonstrated. The porcine xenograft model of Rb with vitreous seeds can serve as a useful platform for testing new treatment modalities in Rb therapy.

  • 2‐Hydroxyethyl Methacrylate Hydrogels for Local Drug Delivery: Study of Topotecan and Vincristine Sorption/Desorption Kinetics and Polymer‐Drug Interaction by ATR‐FTIR Spectroscopy

    by Ana‐Irina Cocarta, Radka Hobzova, Miroslava Trchova, Karel Svojgr, Martina Kodetova, Pavel Pochop, Jiri Uhlik, Jakub Sirc

    Poly(2‐hydroxyethyl methacrylate) (pHEMA) hydrogels are well known in ophthalmological applications and recently investigated as drug delivery systems. The study represents a theoretical approach where the sorption/desorption experiments and spectroscopic study is used to describe the influence of the pHEMA network structure on the sorption capacity and mechanism of the release of topotecan (TPT) and vincristine (VCR). The hydrogels are synthesized by free‐radical crosslinking polymerization of HEMA monomer with ethylene glycol dimethacrylate as a crosslinker in the concentration range from 0.3 to 1 wt%. Experimental data from sorption kinetics are evaluated using sorption kinetic models and sorption isotherms, drug release mechanism is assessed by two different models and attenuated total reflectance Fourier transform infrared (ATR‐FTIR) spectroscopy is employed to describe the polymer‐drug interaction. pHEMA hydrogels exhibit higher affinity for TPT than for VCR and hydrogels prepared with 0.5 wt% of crosslinker show the maximum sorption capacity for both drugs. Physisorption is proved to be the sorption mechanism. Analyzing the FTIR spectra, it is concluded that the hydrophobic crosslinks play an important role in the interaction of the hydrogel backbone with molecules of both drugs.


  • Biocompatible indocyanine green loaded PLA nanofibers for in situ antimicrobial photodynamic therapy

    by Eduard Preis, Thomas Anders, Jakub Širc, Radka Hobzova, Ana-Irina Cocarta, Udo Bakowsky, Jarmila Jedelská


  • Open Access

    Hydrogel Tissue Expanders for Stomatology. Part II. Poly(styrene-maleic anhydride) Hydrogels

    by Jakub Hrib, Eva Chylikova Krumbholcova, Miroslava Duskova-Smrckova, Radka Hobzova, Jakub Sirc, Martin Hruby, Jiri Michalek, Jiri Hodan, Petr Lesny, Roman Smucler

    Self-inflating soft tissue expanders represent a valuable modality in reconstructive surgery. For this purpose, particularly synthetic hydrogels that increase their volume by swelling in aqueous environment are used. The current challenge in the field is to deliver a material with a suitable protracted swelling response, ideally with an induction period (for sutured wound healing) followed by a linear increase in volume lasting several days for required tissue reconstruction. Here, we report on synthesis, swelling, thermal, mechanical and biological properties of novel hydrogel tissue expanders based on poly(styrene-alt-maleic anhydride) copolymers covalently crosslinked with p-divinylbenzene. The hydrogels exerted hydrolysis-driven swelling response with induction period over the first two days with minimal volume change and gradual volume growth within 30 days in buffered saline solution. Their final swollen volume reached more than 14 times the dry volume with little dependence on the crosslinker content. The mechanical coherence of samples during swelling and in their fully swollen state was excellent, the compression modulus of elasticity being between 750 and 850 kPa. In vitro cell culture experiments and in vivo evaluation in mice models showed excellent biocompatibility and suitable swelling responses meeting thus the application requirements as soft tissue expanders.


  • Poly(d,l-lactide)/polyethylene glycol micro/nanofiber mats as paclitaxel-eluting carriers: preparation and characterization of fibers, in vitro drug release, antiangiogenic activity and tumor recurrence prevention

    by Radka Hobzova, Zuzana Hampejsova, Tereza Cerna, Jan Hrabeta, Kristyna Venclikova, Jarmila Jedelska, Udo Bakowsky, Zuzana Bosakova, Miloslav Lhotka, Simon Vaculin, et al.


  • Paclitaxel‐Loaded Polylactide/Polyethylene Glycol Fibers with Long‐Term Antitumor Activity as a Potential Drug Carrier for Local Chemotherapy

    by Johana Plch, Kristyna Venclikova, Olga Janouskova, Jan Hrabeta, Tomas Eckschlager, Katerina Kopeckova, Zuzana Hampejsova, Zuzana Bosakova, Jakub Sirc, Radka Hobzova

    Local application of anticancer agents prolongs the presence time and increases the concentration of drug in the target place and therefore may reduce serious side effects compared to drug systemic administration. The preparation of fibrous materials of polylactide (PLA) and polyethylene glycol (PEG) loaded with paclitaxel (PTX, 1 or 10 wt%) is presented. Scanning electron microscopy proves that PTX is homogeneously incorporated into the fibers. The addition of PEG of various molecular weights (6, 20, or 35 kDa) ensures the release of significantly higher amounts of hydrophobic PTX in a prolonged release time compared to the fibers containing PTX only. Present PLA‐PEG fibrous carriers can serve as a drug depot for PTX since they exhibit significant toxicity for cancer cell lines in several‐day experiment. They are promising for local recurrence therapy, where the initial release is efficient to kill tumor cells and continued release can prevent their subsequent proliferation.


  • Open Access

    Embedding of Bacterial Cellulose Nanofibers within PHEMA Hydrogel Matrices: Tunable Stiffness Composites with Potential for Biomedical Applications

    by Radka Hobzova, Jakub Hrib, Jakub Sirc, Evgeny Karpushkin, Jiri Michalek, Olga Janouskova, Paul Gatenholm

    Bacterial cellulose (BC) and poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels are both considered as biocompatible materials with potential use in various biomedical applications including cartilage, cardiovascular stent, and soft tissue engineering. In this work, the “ever-wet” process based on in situ UV radical polymerization of HEMA monomer in BC nanofibrous structure impregnated with HEMA was used, and a series of BC-PHEMA composites was prepared. The composite structures were characterized by ATR FT-IR spectroscopy, WAXD, SEM, and TEM techniques. The strategy of using densified BC material of various cellulose fiber contents was applied to improve mechanical properties. The mechanical properties were tested under tensile, dynamic shear, and relaxation modes. The final composites contained 1 to 20 wt% of BC; the effect of the reinforcement degree on morphology, swelling capacity, and mechanical properties was investigated. The biocompatibility test of BC-PHEMA composites was performed using mouse mesenchymal stem cells.